Functional diversification of hybridoma produced antibodies by CRISPR/HDR genomic engineering

van der Schoot, J. M. S.; Fennemann, F. L.; Valente, M.; Dolen, Y.; Hagemans, I. M.; Becker, A. M. D.; Le Gall, C. M.; van Dalen, D.; Cevirgel, A.; van Bruggen, J. A. C.; Engelfriet, M.; Fransen, M. F.; Caval, T.; Bentlage, A. E. H.; Nederend, M.; Leusen, J. H. W.; Heck, A. J. R.; Vidarsson, G.; Figdor, C. G.; Verdoes, M.; Scheeren, F. A.

doi:10.1101/551382

Home/Archive/bioRxiv

bioRxiv · 10.1101/551382

Functional diversification of hybridoma produced antibodies by CRISPR/HDR genomic engineering

View original source ↗Export metadata ↓

Abstract

Hybridoma technology is instrumental for the development of novel antibody therapeutics and diagnostics. Recent preclinical and clinical studies highlight the importance of antibody isotype for therapeutic efficacy. However, since the sequence encoding the constant domains is fixed, tuning antibody function in hybridomas has been restricted. Here, we demonstrate a versatile CRISPR/HDR platform to rapidly engineer the constant immunoglobulin domains to obtain recombinant hybridomas which secrete antibodies in the preferred format, species and isotype. Using this platform, we obtained recombinant hybridomas secreting Fab fragments, isotype switched chimeric antibodies, and Fc-silent mutants. These antibody products are stable, retain their antigen specificity, and display their intrinsic Fc-effector functions in vitro and in vivo. Furthermore, we can site-specifically attach cargo to these antibody products via chemo-enzymatic modification. We believe this versatile platform facilitates antibody engineering for the entire scientific community, empowering preclinical antibody research. One Sentence SummaryWe demonstrate a universal CRISPR/HDR based platform for rapid genetic engineering of hybridomas to obtain functionally diverse antibody isotype panels in the species and format of choice.

Source connections

Published article ↗

Explore related subjects

bioengineering Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

van der Schoot, J. M. S., Fennemann, F. L., Valente, M., Dolen, Y., Hagemans, I. M., Becker, A. M. D., Le Gall, C. M., van Dalen, D., Cevirgel, A., van Bruggen, J. A. C., Engelfriet, M., Fransen, M. F., Caval, T., Bentlage, A. E. H., Nederend, M., Leusen, J. H. W., Heck, A. J. R., Vidarsson, G., Figdor, C. G., Verdoes, M., Scheeren, F. A.. 2019-02-15. Functional diversification of hybridoma produced antibodies by CRISPR/HDR genomic engineering. https://doi.org/10.1101/551382

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

1D model simulations suggest biofilms can suppress cathodic H2 bubble formation

Microbial electrosynthesis (MES) electrochemically generates H2 for the reduction of CO2 into acetate by acetogens. So far, the importance of a biofilm on the cathode of such systems remains under debate. Here, we investigated the role of cathodic biofilms through computational modelling. We developed MES-BIOFILM, a comprehensive one-dimensional model to simulate steady-state H2 and CO2 concentration gradients within cathodic biofilms, while accounting for the limited solubility of H2. The effects of key biofilm properties, including thickness, cell density and H2 consumption rate were analysed. Overall, our simulations indicate that cathodic biofilms play an important role in (1) minimizing H2 loss from the system through H2 consumption within the biofilm; and (2) suppressing H2 bubble formation by maintaining the H2 concentrations at the cathode surface below saturation. Our model predicts that the current density at which H2 bubbles begin to form can be increased by 5.5-fold relative to a bare electrode when biofilms exhibit a high cell density and high H2 consumption rate. This effect requires biofilms of at least 50 m thickness, whereas CO2 diffusion limitations arise above 200 m. These findings highlight the critical role of biofilms to increase MES performance, while requiring further experimental validation.

bioengineering↗

bioRxiv2026

RNA-triggered Cas12a2 antibacterial activity and resistance plasmid degradation

Antimicrobial resistance (AMR) necessitates programmable antibacterial strategies with novel mechanisms. Here, we evaluated an inducible intracellular CRISPR/Cas12a2 system in engineered Escherichia coli targeting a chloramphenicol-resistance (Chl) transcript. Cas12a2 activation significantly delayed bacterial growth and reduced recoverable colony-forming units (CFU) by 3-log10 in vitro, and reduced bacterial burdens in a mouse skin wound model. Transcriptomic profiling revealed upregulation of recA, a key mediator of the SOS response. We therefore designed a Chl-recA dual-targeting construct, which produced a greater growth delay than either single-targeting counterpart. The optimized dual-targeting system led to an approximately 4-log10 reduction in bacterial burden in vivo. Furthermore, exploratory qPCR of culture supernatants suggested a treatment-associated decrease in amplifiable plasmid DNA. Overall, this study provides proof-of-concept for resistance-transcript-guided Cas12a2 antibacterial activity and highlights the potential of co-targeting stress-associated transcripts to enhance programmable antimicrobials.

bioengineering↗

bioRxiv2026

Unlocking Targeted Underwater Delivery of Coral Probiotics

The rapid global decline of coral reefs has intensified the need for innovative conservation strategies, including microbial therapies to enhance coral health and resilience. A major limitation, however, is the lack of effective delivery systems for administering Beneficial Microorganisms for Corals (BMCs). In this study, we present natural, biodegradable systems for the underwater delivery of probiotic bacteria to corals. Three customized alginate-based delivery formats (beads, hydrogels, and filaments) were developed and loaded with the probiotic Pseudoalteromonas peptidolytica. The materials were loaded with the bacterium at an average concentration of 10^(4) CFU/g of dry polymer and engineered to sink underwater while keeping their structural integrity over time. In vitro assays showed controlled release kinetics, with encapsulated probiotics remaining viable and capable of replication. In vivo experiments compared syringe-based inoculation with the application of alginate beads, hydrogels, and filaments to corals. Microbiome analyses performed before and after inoculation confirmed successful probiotic colonization following deployment of the alginate-based delivery systems. Relative abundance of the probiotic genus Pseudoalteromonas increased markedly in treated corals, reaching 11.5 % after 48 h with alginate beads, 12.7 % after 48 h with hydrogels, and 12.6 % after 24 h with filaments. Furthermore, the degradation mechanisms of the three delivery systems were investigated. As the first biomaterial-based underwater delivery systems specifically engineered for coral probiotics, these alginate-based materials provide a promising foundation for advancing microbial therapies in both controlled aquaria and natural reef environments.

bioengineering↗